← All stocks

Certara, Inc.

CERT Net buying
CIK 0001827090 #2340 in the set updated 18 Sep 2026
Bought (12 mo)
$200.00K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$200.00K
+$200.00K against sales at will

By person

17 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Feehery William F
CHIEF EXECUTIVE OFFICER
$200.00K (1)
+$200.00K
2,360,769
1.55%
$19.59M
+5.0%
CASHMAN JAMES E III
Director
484,197
0.3174%
$4.02M
+6.1%
Aspbury Robert
PRESIDENT, PREDICTIVE TECH
332,442
0.2179%
$2.76M
+14.9%
WALSH MATTHEW M
Director
213,316
0.1398%
$1.77M
+14.9%
Pedersen Leif E
PRESIDENT, CHIEF COMMERCAL OFF
110,045
0.0721%
$913.37K
+10.4%
Gallagher John E
Chief Financial Officer
95,371
0.0625%
$791.58K
+423.5%
Killefer Nancy
Director
51,846
0.0340%
$430.32K
+114.6%
Collins Cynthia
Director
51,846
0.0340%
$430.32K
+114.6%
BROSHY ERAN
Director
50,708
0.0332%
$420.88K
+120.2%
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
50,091
0.0328%
$415.76K
0.0%
Crane Rosemary A
Director
45,672
0.0299%
$379.08K
+153.9%
Resnick Jon Matthew
Chief Executive Officer
35,389
0.0232%
$293.73K
Corcoran Daniel
SVP and General Counsel
32,046
0.0210%
$265.98K
Reynders John V W
Chief Financial Officer
26,466
0.0174%
$219.67K
Anhalt Rona
Chief Human Resources Officer
16,789
0.0110%
$139.35K
McKemey Adrian
President, Drug Dev. Solutions
8,207
0.0054%
$68.12K
Bedi Arjun
Director
5,547
0.0036%
$46.04K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 515,662
History held since 16 Dec 2020